Physician profile
Heidi C Jackson
NPI 1467486340
$11,195.30
in general payments reported to CMS, 2019-2025
51 companies · $3,256 in 2025
The $3,256 reported for 2025 was more than what 96% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,576 · 2022: $1,725 · 2023: $2,707 · 2024: $1,931 · 2025: $3,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,777 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,777.06 |
| Education | $116.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,735.63 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,256.66 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $803.32 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novo Nordisk INC | $796.95 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $630.28 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $602.26 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Otsuka America Pharmaceutical, INC. | $534.01 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Amgen INC. | $446.00 | 2021-2025 | Repatha, Otezla, Otezla |
| Vanda Pharmaceuticals INC. | $350.82 | 2021-2025 | Fanapt, Hetlioz |
| Bayer Healthcare Pharmaceuticals INC. | $328.90 | 2021-2024 | |
| Pfizer INC. | $317.73 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $285.65 | 2021-2025 | Qelbree, Qelbree |
| Astellas Pharma US INC | $278.06 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.23 | 2021-2022 | |
| Lundbeck LLC | $225.28 | 2022-2025 | Rexulti |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $195.95 | 2022-2025 | Ingrezza |
| Takeda Pharmaceuticals U.S.A., INC. | $187.46 | 2021-2023 | Trintellix |
| Exact Sciences Corporation | $160.98 | 2023-2025 | Cologuard Collection Kit |
| Indivior INC. | $144.75 | 2021-2023 | Sublocade |
| Sunovion Pharmaceuticals INC. | $142.08 | 2021 | |
| Xeris Pharmaceuticals, INC. | $141.06 | 2021-2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $132.97 | 2023-2025 | Cobenfy, Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $124.62 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Merck Sharp & Dohme LLC | $80.19 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Axsome Therapeutics, INC. | $78.18 | 2022-2025 | Auvelity |
| Uswm, LLC | $75.56 | 2023 | Lucemyra |
| Hologic Sales and Service, LLC | $70.95 | 2021-2023 | Aptima, Thinprep 2000 Processor |
| Philips North America LLC | $67.32 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.51 | 2021-2025 | Xifaxan |
| Mylan Specialty L.P. | $52.30 | 2022 | |
| Alkermes, INC. | $49.77 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $48.03 | 2021-2025 | Airsupra, Breztri |
| Biohaven Pharmaceuticals, INC. | $44.39 | 2021 | |
| Tempus Ai, INC | $40.58 | 2024 | |
| Gilead Sciences, INC. | $39.04 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $38.00 | 2025 | |
| Aimmune Therapeutics, INC. | $35.78 | 2025 | Zenpep |
| Collegium Pharmaceutical, INC. | $32.50 | 2021-2025 | Jornay Pm |
| Novartis Pharmaceuticals Corporation | $31.54 | 2022 | |
| Braeburn INC. | $31.19 | 2024-2025 | Brixadi |
| Baxter Healthcare | $29.25 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Welch Allyn Panoptic Ophthalmoscope |
| Dexcom, INC. | $24.54 | 2025 | Dexcom G6 Transmitter |
| Pulmonx Corporation | $23.63 | 2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Medtronic, INC. | $23.00 | 2025 | Minimed 780g |
| Corium, LLC | $22.15 | 2025 | Azstarys |
| Tris Pharma INC | $18.99 | 2025 | Onyda Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $18.86 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.46 | 2024 | Quviviq |
| Ironshore Pharmaceuticals INC. | $17.44 | 2024 | |
| Abiomed | $15.78 | 2025 | |
| Averitas Pharma INC. | $14.72 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.